149 related articles for article (PubMed ID: 38057660)
21. Role of Whole-Genome Sequencing in Characterizing the Mechanism of Action of
Satta G; Witney AA; Begum N; Ortiz Canseco J; Boa AN; McHugh TD
Antimicrob Agents Chemother; 2020 Aug; 64(9):. PubMed ID: 32571810
[No Abstract] [Full Text] [Related]
22. para-Aminosalicylic acid is a prodrug targeting dihydrofolate reductase in Mycobacterium tuberculosis.
Zheng J; Rubin EJ; Bifani P; Mathys V; Lim V; Au M; Jang J; Nam J; Dick T; Walker JR; Pethe K; Camacho LR
J Biol Chem; 2013 Aug; 288(32):23447-56. PubMed ID: 23779105
[TBL] [Abstract][Full Text] [Related]
23. Para-aminosalicylic acid acts as an alternative substrate of folate metabolism in Mycobacterium tuberculosis.
Chakraborty S; Gruber T; Barry CE; Boshoff HI; Rhee KY
Science; 2013 Jan; 339(6115):88-91. PubMed ID: 23118010
[TBL] [Abstract][Full Text] [Related]
24. Whole-Genome Sequencing for Drug Resistance Profile Prediction in
Gygli SM; Keller PM; Ballif M; Blöchliger N; Hömke R; Reinhard M; Loiseau C; Ritter C; Sander P; Borrell S; Collantes Loo J; Avihingsanon A; Gnokoro J; Yotebieng M; Egger M; Gagneux S; Böttger EC
Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30718257
[TBL] [Abstract][Full Text] [Related]
25. Comparisons of whole-genome sequencing and phenotypic drug susceptibility testing for Mycobacterium tuberculosis causing MDR-TB and XDR-TB in Thailand.
Faksri K; Kaewprasert O; Ong RT; Suriyaphol P; Prammananan T; Teo YY; Srilohasin P; Chaiprasert A
Int J Antimicrob Agents; 2019 Aug; 54(2):109-116. PubMed ID: 30981926
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of whole-genome sequence to predict drug resistance of nine anti-
Che Y; Lin Y; Yang T; Chen T; Sang G; Chen Q; He T
Front Public Health; 2022; 10():956171. PubMed ID: 36062095
[TBL] [Abstract][Full Text] [Related]
27. Genome-wide DNA methylation and transcriptome and proteome changes in Mycobacterium tuberculosis with para-aminosalicylic acid resistance.
Li HC; Chen T; Yu L; Guo HX; Chen L; Chen YH; Chen M; Zhao J; Yan HM; Zhou L; Wang W
Chem Biol Drug Des; 2020 Jan; 95(1):104-112. PubMed ID: 31562690
[TBL] [Abstract][Full Text] [Related]
28. Mycobacterium tuberculosis whole genome sequencing provides insights into the Manila strain and drug-resistance mutations in the Philippines.
Phelan JE; Lim DR; Mitarai S; de Sessions PF; Tujan MAA; Reyes LT; Medado IAP; Palparan AG; Naim ANM; Jie S; Segubre-Mercado E; Simoes B; Campino S; Hafalla JC; Murase Y; Morishige Y; Hibberd ML; Kato S; Ama MCG; Clark TG
Sci Rep; 2019 Jun; 9(1):9305. PubMed ID: 31243306
[TBL] [Abstract][Full Text] [Related]
29. Analysis of mutations leading to para-aminosalicylic acid resistance in Mycobacterium tuberculosis.
Pandey B; Grover S; Kaur J; Grover A
Sci Rep; 2019 Sep; 9(1):13617. PubMed ID: 31541138
[TBL] [Abstract][Full Text] [Related]
30. Population genetics study of isoniazid resistance mutations and evolution of multidrug-resistant Mycobacterium tuberculosis.
Hazbón MH; Brimacombe M; Bobadilla del Valle M; Cavatore M; Guerrero MI; Varma-Basil M; Billman-Jacobe H; Lavender C; Fyfe J; García-García L; León CI; Bose M; Chaves F; Murray M; Eisenach KD; Sifuentes-Osornio J; Cave MD; Ponce de León A; Alland D
Antimicrob Agents Chemother; 2006 Aug; 50(8):2640-9. PubMed ID: 16870753
[TBL] [Abstract][Full Text] [Related]
31. Cross-sectional Whole-genome Sequencing and Epidemiological Study of Multidrug-resistant Mycobacterium tuberculosis in China.
Huang H; Ding N; Yang T; Li C; Jia X; Wang G; Zhong J; Zhang J; Jiang G; Wang S; Zong Z; Jing W; Zhao Y; Xu S; Chen F
Clin Infect Dis; 2019 Jul; 69(3):405-413. PubMed ID: 30321294
[TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetics of para-aminosalicylic acid in HIV-uninfected and HIV-coinfected tuberculosis patients receiving antiretroviral therapy, managed for multidrug-resistant and extensively drug-resistant tuberculosis.
de Kock L; Sy SK; Rosenkranz B; Diacon AH; Prescott K; Hernandez KR; Yu M; Derendorf H; Donald PR
Antimicrob Agents Chemother; 2014 Oct; 58(10):6242-50. PubMed ID: 25114132
[TBL] [Abstract][Full Text] [Related]
33. Second-line drug susceptibilities of multidrug-resistant tuberculosis strains isolated in Thailand: an update.
Chaiprasert A; Srimuang S; Tingtoy N; Makhao N; Sirirudeeporn P; Tomnongdee N; Theankeaw O; Charoensook S; Leechawengwongs M; Prammananan T
Int J Tuberc Lung Dis; 2014 Aug; 18(8):961-3. PubMed ID: 25199012
[TBL] [Abstract][Full Text] [Related]
34. Analysis of Serial Multidrug-Resistant Tuberculosis Strains Causing Treatment Failure and Within-Host Evolution by Whole-Genome Sequencing.
Chen X; He G; Lin S; Wang S; Sun F; Chen J; Zhang W
mSphere; 2020 Dec; 5(6):. PubMed ID: 33361124
[TBL] [Abstract][Full Text] [Related]
35. Genome sequencing of Mycobacterium tuberculosis clinical isolates revealed isoniazid resistance mechanisms undetected by conventional molecular methods.
Laurent S; Zakham F; Bertelli C; Merz L; Nicod L; Mazza-Stalder J; Greub G; Jaton K; Opota O
Int J Antimicrob Agents; 2020 Aug; 56(2):106068. PubMed ID: 32603684
[TBL] [Abstract][Full Text] [Related]
36. Diversified lineages and drug-resistance profiles of clinical isolates of
Noorizhab Fakhruzzaman MN; Abidin NZ; Aziz ZA; Lim WF; Richard JJ; Noorliza MN; Hani MH; Norhayati R; Zamzurina AB; Farida Zuraina MY; Hisyam MJ; Teh LK; Norazmi MN; Zaki MS
Int J Mycobacteriol; 2019; 8(4):320-328. PubMed ID: 31793500
[TBL] [Abstract][Full Text] [Related]
37. Correlation of drug resistance with single nucleotide variations through genome analysis and experimental validation in a multi-drug resistant clinical isolate of M. tuberculosis.
Bhattacharyya K; Nemaysh V; Joon M; Pratap R; Varma-Basil M; Bose M; Brahmachari V
BMC Microbiol; 2020 Jul; 20(1):223. PubMed ID: 32711461
[TBL] [Abstract][Full Text] [Related]
38. Novel mutations detected from drug resistant Mycobacterium tuberculosis isolated from North East of Thailand.
Thwe EP; Namwat W; Pinlaor P; Rueangsak K; Sangka A
World J Microbiol Biotechnol; 2021 Oct; 37(11):194. PubMed ID: 34642828
[TBL] [Abstract][Full Text] [Related]
39. Minor contribution of mutations at iniA codon 501 and embC-embA intergenic region in ethambutol-resistant clinical Mycobacterium tuberculosis isolates in Kuwait.
Jaber AA; Ahmad S; Mokaddas E
Ann Clin Microbiol Antimicrob; 2009 Jan; 8():2. PubMed ID: 19146672
[TBL] [Abstract][Full Text] [Related]
40. Accuracy of whole genome sequencing versus phenotypic (MGIT) and commercial molecular tests for detection of drug-resistant Mycobacterium tuberculosis isolated from patients in Brazil and Mozambique.
Feliciano CS; Namburete EI; Rodrigues Plaça J; Peronni K; Dippenaar A; Warren RM; Silva WA; Bollela VR
Tuberculosis (Edinb); 2018 May; 110():59-67. PubMed ID: 29779775
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
